OSE Immunotherapeutics SA banner

OSE Immunotherapeutics SA
PAR:OSE

Watchlist Manager
OSE Immunotherapeutics SA Logo
OSE Immunotherapeutics SA
PAR:OSE
Watchlist
Price: 3.322 EUR -2.52% Market Closed
Market Cap: €75.3m

Wall St Price Targets

OSE Price Targets Summary
OSE Immunotherapeutics SA

Wall Street analysts forecast OSE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OSE is 13.464 EUR with a low forecast of 8.282 EUR and a high forecast of 22.05 EUR.

Lowest Forecast
Price Target
8.282 EUR
149% Upside
Average Forecast
Price Target
13.464 EUR
305% Upside
Highest Forecast
Price Target
22.05 EUR
564% Upside
OSE Immunotherapeutics SA Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Revenue over the next 4 years is 5%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
39%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
39%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is OSE's stock price target?
Price Target
13.464 EUR

According to Wall Street analysts, the average 1-year price target for OSE is 13.464 EUR with a low forecast of 8.282 EUR and a high forecast of 22.05 EUR.

What is the Revenue forecast for OSE Immunotherapeutics SA?
Projected CAGR
5%

The compound annual growth rate for Revenue over the next 4 years is 5%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett